Abstract: Salts of pentamidine, formulations containing such salts and the use of such salts of treatment or prophylaxis of pneumocystis carinii. Pentamidine gluconate and lactate has been discovered and found to have high water solubility while providing potentially less toxic alternatives to pentamidine isethionate, especially for aerosolized administration to patients suffering from acquired immunodeficiency syndrome, AIDS, or AIDS related complex, ARC.
Type:
Grant
Filed:
July 19, 1989
Date of Patent:
January 28, 1992
Assignee:
Fujisawa USA, Inc.
Inventors:
Sadanand Pai, Abu S. Alam, John N. Kapoor
Abstract: Mono-, di- and triphenols are selectively monomethylated by reaction with para-dimethoxybenzene in the presence of a catalytically effective amount of an acid catalyst.
Abstract: Calcium lactate-glycerol adduct, a molecular compound of 1 mole of calcium lactate and 2 moles of glycerol, and a process for its preparation are described. The adduct can be used as a calcium donor or auxiliary in pharmacy, cosmetics and the production of foodstuffs.
Abstract: A process for preparing .alpha.-formylamino nitriles of the formula I ##STR1## where R.sup.1 and R.sup.2 are each hydrogen or unsubstituted or substituted, with substituents which are inert under the reaction conditions, aliphatic or heteroaliphatic radicals with 1 to 10, cycloaliphatic or heterocycloaliphatic radicals with 3 to 6, araliphatic radicals with 7 to 12, heteroaraliphatic radicals with 4 to 12, aromatic radicals with 6 to 10 or heteroaromatic radicals with 3 to 10 carbon atoms, by reacting cyanohydrins of the formula II ##STR2## with the formamide III ##STR3## in the presence of acids, entails adding at least one ammonium salt to the reaction mixture.
Abstract: A process is provided for producing N-phosphonomethylglycine by the oxidation of N-phosphonomethyliminodiacetic acid with a peroxide to form an intermediate N-phosphonomethyliminodiacetic acid-N-oxide. Thereafter, the N-phosphonomethyliminodiacetic acid-N-oxide is converted to N-phosphonomethylglycine by adding a catalytic amount of a metal selected from the group consisting of iron, zinc, aluminum, vanadium and copper, or a compound selected from the group consisting of water-soluble vanadium compounds, ferrous salts and cuprous salts.
Abstract: Neutral lipids are provided characterized by binding to phorboid and ingenoid receptors. These lipids are found in a wide variety of cellular sources as well as milk and may be isolated by specific extraction and chromatographic procedures. Depending upon the source, the glycerides may be mono- or di-glycerides, wherein the total number of carbon atoms of the fatty acids is in the range of 18 to 26, so that the monoglyceride has a fatty acid of at least 18 carbon atoms, while the di-glyceride has a fatty acid of at least 14 carbon atoms.
Abstract: A process is provided for producing N-phosphonomethylglycine by the oxidation of N-phosphonomethyliminodiacetic acid with a peroxide to form an intermediate N-phosphonomethyliminodiacetic acid-N-oxide. Thereafter, the N-phosphonomethyliminodiacetic acid-N-oxide is converted to N-phosphonomethylglycine by adding a catalytic amount of a metal selected from the group consisting of iron, zinc, aluminum, vanadium and copper, or a compound selected from the group consisting of water-soluble vanadium compounds, ferrous salts and cuprous salts.
Abstract: Compounds of general formula ##STR1## in which: M is an alkaline earth metal,R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and i being defined in the description.Medicaments.
Type:
Grant
Filed:
February 15, 1991
Date of Patent:
December 24, 1991
Assignee:
Adir et Compagnie
Inventors:
Stanislas Czernecki, Claude Fugier, Yannis Tsouderos
Abstract: A process for the production of N-phosphonomethylglycine comprising contacting N-phosphonomethyliminodiacetic acid with a peroxide in the presence of a catalyst selected from the group consisting of the salts and salt complexes of cobalt and vanadium, and an effective amount of a quinone or hydroquinone.
Type:
Grant
Filed:
December 11, 1990
Date of Patent:
December 10, 1991
Assignee:
Monsanto Company
Inventors:
Donald L. Fields, Jr., Raymond C. Grabiak, Karl E. Koenig, Dennis P. Riley
Abstract: There is disclosed herein improved processes for the preparation of ether carboxylates by reacting in an alkaline reaction medium the salts of maleic acid and malic acid in the presence of a calcium ion catalyst wherein unreacted acid salts are recovered from the reaction medium by lowering the pH of the reaction medium to a range of from about 4 to about 6 in two steps, the first step ending at a pH in the range of from about 7 to about 8.5. The precipitate is removed and the pH of the reaction medium is then lowered further to a pH in the range of from 4 to 6. The precipitated salts are recycled to the synthesis reaction to prepared additional amounts of product.
Abstract: 2-Chloro and 2,6-dichloroanilines, optionally substituted in the 3-, 5-, and/or 6-position are prepared from the corresponding anilides by selective bromination, chlorination, reduction and hydrolysis. The selectivity of the process for introducing chlorines ortho to the amino group is very high.
Abstract: A process for continuous preparation of a concentrated aqueous solution of glyoxylic acid by hydrolysis of glyoxylic acid ester hemiacetals, wherein glyoxylic acid ester hemiacetals are treated with steam in countercurrent in a reactor cascade.
Type:
Grant
Filed:
May 25, 1990
Date of Patent:
November 26, 1991
Assignee:
Chemie Linz Gesellschaft m.b.H.
Inventors:
Alexander Sajtos, Engelbert Kloimstein, Karl Hollinger, Lorenz Farnlettner
Abstract: A process for producing highly pure 2,6-napthalene dicarboxylic acid, characterized by hydrolyzing 2,6-dimethyl naphthalene dicarboxylate more than 99% pure in an aqueous solution by using an aromatic poly-carboxylic acid as a catalyst is disclosed.
Abstract: A process for the preparation of aromatic aldehydes by formylation of aromatic compounds in liquid hydrofluoric acid in the presence of boron trifluoride.
Abstract: Lactic acid is separated from a fermentation broth by using an adsorbent comprising a water-insoluble macroreticular or gel weakly basic anionic exchange resin possessing tertiary amine or pyridine functional groups or a strongly basic anionic exchange resin possessing quaternary amine fuctional groups. The resins are in sulfate form and have a cross-linked acrylic or styrene resin matrix. Lactic acid is desorbed with water or dilute inorganic acid, e.g., sulfuric. The pH of the feed is maintained below the ionization constant (pKa) of lactic acid to obtain high selectivity.
Abstract: The method according to the present invention comprises purification of 2,2'-di-(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-naphthaldehyde) by crystallization from a solution thereof in diethyl ether with a concentration of 0.002-0.2 g/ml by adding 0.25-3 parts of hexane by volume (of diethyl ether) keeping the mixture at a temperature of from 10.degree. to 30.degree. C., separation of the resulting precipitate and drying thereof to give the desired product.
Type:
Grant
Filed:
July 16, 1990
Date of Patent:
October 22, 1991
Inventors:
Bakhtiyar T. Ibragimov, Samat A. Talipov, Rustam G. Mardanov, Takhir F. Aripov
Abstract: Ortho-substituted 1-napthyl ethers of the formula ##STR1## where X is CH or N, Y is saturated or unsaturated alkylene and R is aryl, aryloxy, arylthio or arylalkoxy, the aromatic ring being substituted or unsubstituted, and fungicides containing these compounds.
Type:
Grant
Filed:
February 2, 1990
Date of Patent:
October 15, 1991
Assignee:
BASF Aktiengesellschaft
Inventors:
Bernd Wenderoth, Hubert Sauter, Albrecht Harreus, Franz Roehl, Eberhard Ammermann, Gisela Lorenz
Abstract: A process for preparing N-substituted amino acid esters having the formula (I): ##STR1## wherein R.sub.1 and R.sub.4, the same or different, are an alkyl, aralkyl, cycloalkyl or aryl group; and R.sub.2 and R.sub.3, the same or different,are an alkyl, aralkyl, aryl, heterocycle-alkyl, aminoalkyl or guanidylalkyl, by the reaction of .alpha.-amino acid esters with .alpha.-substituted carboxylic acid esters, under the condition of substantially free from solvent, which can afford their optical isomers in a good yield.
Abstract: The present invention relates to a method for inhibiting the phosphatidylinositol cycle in a cell by contacting the cell with certain myo-inositol analogs. Such myo-inositol analogs can also be utilized to treat phosphatidylinositol cycle-dependent conditions. The present invention also provides novel myo-inositol analogs.
Abstract: A process for producing an .alpha.-hydroxyisobutyric acid which comprises hydrolyzing .alpha.-hydroxyisobutyric acid ester in the presence of an organic sulfonic acid catalyst, using an .alpha.-hydroxyisobutyric acid ester as the starting material.According to said process, .alpha.-hydroxyisobutyric acid can be efficiently produced.